One Size Doesn’t Fit All for Access to Emerging Markets

While the global biopharma industry retains its huge dependence on the U.S. market, emerging ...

Rethinking the Launch—Don’t Fall into the Recent Trend of Underwhelming Results

Here’s the fact: since the pandemic, launch revenues in pharma have declined. Doesn’t matter ...

Beyond the Media Buy: Opening the Pandora’s Box of Point-of-Care Program Measurement

As pharma companies began to professionalize their point-of-care (POC) messaging strategies, they moved to ...

Moving Beyond the Transactional

“Go take a nap,” my husband told me. I had been complaining about the ...

Helping to Improve Hygiene Can Lower Disease Burden in Low- and Middle-Income Countries

The increasing urbanization in low- and middle-income countries (LMICs) is closely linked to the ...

Engaging the Audience Hiding in Plain View

Traditionally, when pharma marketers and their strategy, creative, and media agencies develop marketing plans, ...

The Omnichannel Ecosystem: It’s More Than a Strategy

The healthcare marketing industry is changing and has been for some time. A sales ...

Nourishing Better Advocacy for Patients

Adopting a patient-centric approach to communications yields many benefits, from improving patient self-care, to ...

Does DTC Make Sense for Psychedelic Launches?

In June of this year, Nature reported1 that Australia passed legislation allowing clinicians to ...

6 Things to Consider to Build Creative that Makes an Impact

Last we spoke, executing omnichannel digital media using programmatic as the foundation was the ...